Replimune (REPL) Other Non Operating Income (2017 - 2025)

Replimune's (REPL) quarterly Other Non Operating Income came in at -$580000.0 in Q4 2025, up 82.32% year-on-year from -$318117.7 in Q4 2024, and up 33.79% quarter-over-quarter from -$876000.0 in Q3 2025.

Replimune (REPL) Other Non Operating Income (2017 - 2025) Analysis & Trends

Replimune has disclosed Other Non Operating Income across 9 years of filings, most recently posting -$580000.0 for Q4 2025.

  • Other Non Operating Income for Q4 2025 came in at -$580000.0, up 82.32% year-over-year; the trailing twelve-month figure through Dec 2025 was -$217000.0 (up 84.31% YoY), and the FY2025 annual result was -$202000.0, down 126.2% from the prior year.
  • Other Non Operating Income came in at -$580000.0 for Q4 2025 at Replimune, up from -$876000.0 in the prior quarter.
  • In the past five years, Other Non Operating Income ranged from a high of $2.0 million in Q3 2024 to a low of -$3.3 million in Q4 2024.
  • The 5-year median for Other Non Operating Income is -$246500.0 (2021), against an average of -$347000.0.
  • Across the five-year window, Other Non Operating Income tumbled 800.0% in 2021 and surged 814.29% in 2023, its largest moves.
  • Replimune's Other Non Operating Income stood at -$241000.0 in 2021, then surged by 161.0% to $147000.0 in 2022, then soared by 814.29% to $1.3 million in 2023, then sank by 344.12% to -$3.3 million in 2024, then soared by 82.32% to -$580000.0 in 2025.
  • The last three Other Non Operating Income figures came in at -$580000.0 (Q4 2025), -$876000.0 (Q3 2025), and $591000.0 (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 762,369.55 Bn 762,369.51 Bn -
2 Belite Bio 55,096.00 Bn 55,096.00 Bn -
3 Quantum Biopharma 17,755.80 Bn 17,755.79 Bn -
4 Legend Biotech 3,486.00 Bn 3,485.71 Bn 242.10 Mn
5 Akari Therapeutics 1,737.42 Bn 1,737.41 Bn -
6 Evaxion A 1,551.28 Bn 1,551.26 Bn -
7 Psyence Biomedical 227.32 Bn 227.31 Bn -
8 Vertex Pharmaceuticals 110.84 Bn 103.59 Bn 2.59 Bn
9 Abivax 91.71 Bn 91.71 Bn -
10 Replimune 780.01 Mn 510.88 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2025 -580,000.00
Sep 30, 2025 -876,000.00
Jun 30, 2025 591,000.00
Mar 31, 2025 648,000.00
Dec 31, 2024 -3.28 Mn
Sep 30, 2024 2.03 Mn
Jun 30, 2024 406,000.00
Mar 31, 2024 -536,000.00
Dec 31, 2023 1.34 Mn
Sep 30, 2023 -1.41 Mn
Jun 30, 2023 1.37 Mn
Mar 31, 2023 -1.15 Mn
Dec 31, 2022 147,000.00
Sep 30, 2022 -2.66 Mn
Jun 30, 2022 -2.02 Mn
Mar 31, 2022 -210,000.00
Dec 31, 2021 -241,000.00
Sep 30, 2021 -356,000.00
Jun 30, 2021 -252,000.00
Mar 31, 2021 86,000.00